Endometrial Microbiome and Implantation: From Basic Knowledge to Clinical Medicine
Reproductive Medicine and Biology · 2026-01 · 25 (1)
DOI: 10.1002/rmb2.70040 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reproductive Medicine and Biology, online erschienen am 12.03.2026. Verfasst von Daiki Hiratsuka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Graduate School of Medicine The University of Tokyo Tokyo Japan. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Japan Science and Technology Agency.
Abstract (Originalsprache)
Background
Recurrent implantation failure (RIF) is an infertility condition in which uterine factors remain difficult to diagnose and treat. Recent studies implicate the endometrial microbiome in implantation.
Methods
This clinically oriented narrative review summarizes female reproductive tract microbiota and evidence on endometrial microbiome testing and management in infertility. Main Findings (Results) Vaginal dysbiosis is linked to adverse reproductive outcomes and provides a reference for interpreting upper‐tract findings. Endometrial microbial signals are detectable by sequencing, but interpretation is challenged by the low‐biomass environment and vulnerability to carry‐over, kitome effects, and contamination. Across ART studies, a Lactobacillus ‐enriched endometrial profile is more often associated with favorable pregnancy‐related outcomes, whereas non– Lactobacillus ‐dominant patterns are more frequently reported in implantation failure, although effect sizes and statistical significance vary across cohorts and depend on sampling validity and cutoff definitions. Limited nonrandomized intervention studies suggest that testing‐guided targeted management (typically antibiotics with or without vaginal Lactobacillus ‐containing probiotics) may benefit selected patients, but protocols are heterogeneous and results remain inconsistent.
Conclusion
Evidence is rapidly evolving, yet observational designs and methodological variability limit causal inference. Future progress will require standardized sampling and contamination controls, outcome‐anchored threshold validation, and pragmatic real‐world evaluations of protocolized test‐and‐treat pathways using clinically meaningful endpoints.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Graduate School of Medicine The University of Tokyo Tokyo Japan.
ORCID-Profile: Daiki Hiratsuka
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
- Japan Science and Technology Agency
Zitieren
APA
Hiratsuka, D., Matsuo, M., & Hirota, Y. (2026). Endometrial Microbiome and Implantation: From Basic Knowledge to Clinical Medicine. Reproductive Medicine and Biology, 25(1). https://doi.org/10.1002/rmb2.70040
Vancouver
Hiratsuka D, Matsuo M, Hirota Y. Endometrial Microbiome and Implantation: From Basic Knowledge to Clinical Medicine. Reproductive Medicine and Biology. 2026;25(1). doi:10.1002/rmb2.70040
BibTeX
@article{Hiratsuka2026,
author = {Hiratsuka, Daiki and Matsuo, Mitsunori and Hirota, Yasushi},
title = {Endometrial Microbiome and Implantation: From Basic Knowledge to Clinical Medicine},
journal = {Reproductive Medicine and Biology},
year = {2026},
volume = {25},
number = {1},
doi = {10.1002/rmb2.70040}
}
EUVIMED